VitaNova Life Sciences Corporation (VNOV)

OTCMKTS · Delayed Price · Currency is USD

1.380

0.00 (0.00%)

Apr 20, 2026, 12:00 PM EST

VitaNova Life Sciences Financials Overview

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Revenue	3.03	3.03	2.66	0.57	0.04	0.12
Revenue Growth	13.65%	13.65%	366.47%	1401.83%	-68.33%	-
Gross Profit	0.91	0.91	1.58	0.38	0.04	0.12
Operating Income	0	0	1.21	0.21	-0.02	-0.01
Net Income	-0.04	-0.04	0.85	0.14	-0.02	0.14
Earnings Per Share	-0.00	-0.00	0.10	0.04	-0.01	0.06
EPS Growth	-	-	157.00%	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Healthy Food Products	1.06	1.06	-	-	-	-
Dietary Supplement Segment	1.95	1.95	2.65	0.54	-	-
Consulting Services Segment	0.02	0.02	0.01	0.03	0.04	0.12
Total	3.03	3.03	2.66	0.57	0.04	0.12

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Cash & Investments	1.6	1.6	0.78	0.59	0.01	0.02
Total Debt	-	-	-	0	0.02	0.01
Net Cash (Debt)	1.6	1.6	0.78	0.59	-0.01	0.01
Net Cash Growth	104.04%	104.04%	32.67%	-	-	-
Net Cash Per Share	0.19	0.19	0.09	0.17	-0.00	0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Operating Cash Flow	0.81	0.81	0.19	-0.38	-0.02	0
Capital Expenditures	-	-	-	-	-	-
Free Cash Flow	0.81	0.81	0.19	-0.38	-0.02	0
Free Cash Flow Growth	322.47%	322.47%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 30, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Gross Margin	30.10%	30.10%	59.19%	66.19%	100.00%	100.00%
Operating Margin	0.12%	0.12%	45.39%	36.03%	-63.75%	-11.14%
Pretax Margin	0.22%	0.22%	45.24%	36.05%	-63.76%	116.40%
Profit Margin	-1.23%	-1.23%	31.96%	24.68%	-63.75%	116.40%
FCF Margin	26.92%	26.92%	7.24%	-65.86%	-48.35%	3.38%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 12, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
PE Ratio	-	-	5.29	106.54	-	21.44
P/FCF Ratio	24.37	14.13	23.36	-	-	737.34
PS Ratio	6.56	3.80	1.69	26.30	463.52	24.95